The JSE was stronger on Wednesday alongside European markets as developments in the search for a coronavirus vaccine supported risk appetite.
News that an experimental Covid-19 vaccine trial by US biotech company Moderna has shown immune response in all 45 volunteer patients, lifted market sentiment amid concerns about the rising number of Covid-19 cases.A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.
Nigeria Nigeria Latest News, Nigeria Nigeria Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
MARKET WRAP: Global risk aversion weakens JSEAs Covid-19 surges globally, and more lockdowns are imposed, safe-haven gold is back in vogue
Source: BDliveSA - 🏆 12. / 63 Read more »
MARKET WRAP: Global economic recovery hopes fuel rand rallyThis week focus shifts to US corporate earnings for the second quarter as investors try to gauge the effect Covid-19 has had on companies there
Source: BDliveSA - 🏆 12. / 63 Read more »
FREE WEBINAR | Connecting the youth market with your brandJoin the Sunday Times Gen Next digital series on Thurs, July 16 at 10am – the speakers will focus on standout campaigns, as voted for by SA’s youth, and aim to help redefine meaningful storytelling and prepare you for the future of marketing.
Source: TimesLIVE - 🏆 28. / 59 Read more »
Source: TheCitizen_News - 🏆 6. / 75 Read more »
Market data — July 13 2020Market data including bonds and fuel prices
Source: BDliveSA - 🏆 12. / 63 Read more »